BD completes acquisition of Edwards Lifesciences' Critical Care product group to expand its smart connected care solutions portfolio
Acquiring Company
Bard
Acquired Company
Edwards Lifesciences
United StatesIrvineManufacturingHealth CareManufacturingBiotechnologyHealthcareHealth CareArtificial IntelligenceMedicalMedical DeviceDescription
BD has completed the acquisition of Edwards Lifesciences' Critical Care product group, which will be renamed as BD Advanced Patient Monitoring. This acquisition expands BD's portfolio of smart connected care solutions with leading monitoring technologies, advanced AI-enabled clinical decision tools, and a robust innovation pipeline. BD Advanced Patient Monitoring will be based in Irvine, Calif. and become part of BD Medical segment, with Katie Szyman continuing to lead as worldwide president.
Quick answer
Bard is acquiring Edwards Lifesciences, announced September 3, 2024. Bard is based in United States.
- How much did Bard pay for Edwards Lifesciences?
- The deal value was not disclosed.
- What does Bard do?
- Bard is a leading provider of medical technologies, including devices for urology, oncology, and vascular medicine.
- Where are Bard and Edwards Lifesciences based?
- Bard is based in United States. Edwards Lifesciences is based in Irvine, California, United States.
- Who are the decision-makers at Bard?
- Fundz holds 2 contacts at Bard. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Other recent acquisitions in Healthcare and Medical
Deals where the buyer or target shares a sector with this one, within 45 days, from Fundz verified event records.
- Edwards Lifesciences Completes Acquisitions of JenaValve Technology and Endotronix (July 24, 2024)
- Becton, Dickinson and Company (BDX) completes acquisition of Critical Care from Edwards Lifesciences (September 3, 2024)
- Flat Medical strengthens market leadership with acquisition of InjeQ assets, including FDA-Designated Breakthrough Device IQ-Tip® (September 25, 2024)
- KARL STORZ completes acquisition of Asensus Surgical, Inc. to strengthen its position in robotic and digital surgical market (August 22, 2024)
- Vitalograph acquires Morgan Scientific to strengthen US commercial footprint (September 23, 2024)
- Trudell Medical Limited to acquire Vyaire Medical RDx, expanding into respiratory diagnostics (August 22, 2024)
Who to call at Bard, and when
When Bard changes hands, the new owners review vendors, systems and leadership. That is when the door opens.
- An alert the day Bard raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Bard, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Bard. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Bard makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Frequently asked
Who acquired Edwards Lifesciences?
Edwards Lifesciences was acquired by Bard, based in United States. The deal was reported on September 5, 2024. Bard is a leading provider of medical technologies, including devices for urology, oncology, and vascular medicine. Bard is privately held and operates in Manufacturing.
When did Bard acquire Edwards Lifesciences?
Bard's acquisition of Edwards Lifesciences was reported on September 5, 2024. BD has completed the acquisition of Edwards Lifesciences' Critical Care product group, which will be renamed as BD Advanced Patient Monitoring. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Edwards Lifesciences do?
Edwards Lifesciences is the global leader of patient-focused innovations for structural heart disease and critical care monitoring. It is privately held, operating in Manufacturing, and is based in Irvine.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.